Basilio, Shierly .
HRN: 12-51-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
CEFUROXIME 500MG (TAB)
08/06/2024
08/13/2024
PO
500mg
BID
AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes